| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.094 | 0.09 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.09 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.09 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.062 | 0.09 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.09 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.062 | 0.09 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.09 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.09 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.058 | 0.09 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.09 |